Skip to content

Maryam Nazemzadeh, M.D.

NPI 1972738508ActiveIndividual· Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery· Ashburn, VA

Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery (M.D.) in Ashburn, Virginia, licensed in VA, with an NPI issued in May 2009. Part D covered 42 prescriptions written in 2024, 95% of them generic. Galderma Laboratories, L.P. was the largest of 3 companies reporting payments in 2025, $233.48 in all, mostly food and beverage.

Overview

NPI1972738508
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedMay 27, 2009
Last updated in NPPESOct 5, 2021
Certified by providerOct 5, 2021

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)42 · 42 30-day fills
Patients12
Total drug cost$464.65
Generic share95% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$233.48 · 7 payments from 3 companies
  • 2024$356.00 · 10 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$233.48 · 7 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records